Skip to main content
IM

Immunowake

Birmingham, United States
Last funding
$20.0M
Series AMay 2022

Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies.

Backed byLapam CapitalSouth China Venture CapitalHEDA VenturesHyfinity Investments

About Immunowake

How much funding has Immunowake raised?

Immunowake has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in May 2022.

Who are Immunowake's investors?

Immunowake's investors include Lapam Capital, South China Venture Capital, HEDA Ventures, Hyfinity Investments.

Where is Immunowake headquartered?

Immunowake is headquartered in Birmingham, United States.

What does Immunowake do?

Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies.

What stage is Immunowake at?

Immunowake is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Immunowake — Funding & Investors." VCBacked, May 15, 2022, https://www.vcbacked.co/company/immunowake. Accessed November 15, 2026.
APA
VCBacked. (2022). Immunowake — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/immunowake
Wikipedia (cite web)
{{cite web |title=Immunowake — Funding & Investors |url=https://www.vcbacked.co/company/immunowake |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Immunowake? Request a listing update

Founder contacts
m***@immunowake.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →